Results 41 to 50 of about 1,201,269 (362)

Quality of life changes during adjuvant chemotherapy in patients with colon cancer [PDF]

Korean Journal of Clinical Oncology, 2016
Purpose: The survival of advanced colon cancer patients has increased due to the development of surgical techniques and adjuvant chemotherapy. The administration of adjuvant chemotherapy after curative resection is generally accepted as a standard of ...
Seo Hee Lee, Taek-Gu Lee, Moo Jun Baek, Jang Jin Kim, Sung-Su Park, Sang-Jeon Lee   +5 more
doaj   +1 more source

Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival [PDF]

Korean Journal of Clinical Oncology, 2021
Purpose Adjuvant chemotherapy is recommended after curative surgery in patients with colon cancer of high-risk stage II and stage III. However, a considerable number of patients cannot complete the scheduled adjuvant treatment for various reasons.
Jieun Kim, Ri Na Yoo, Hyeon-Min Cho, Bong-Hyeon Kye, Hyung Jin Kim   +4 more
doaj   +1 more source

Mathematical modeling of the treatment response of resection plus combined chemotherapy and different types of radiation therapy in a glioblastoma patient [PDF]

arXiv, 2023
Background: Gliomas are the most common brain tumors, which vary from low to high-grade. Despite the improvements in imaging techniques in the last decade, all parts of the tumor are not visible in these images, due to having a threshold of detection often lower than most of the tumor.
arxiv  

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.

JAMA Surgery, 2019
Importance The patterns of disease recurrence after resection of pancreatic ductal adenocarcinoma with adjuvant chemotherapy remain unclear. Objective To define patterns of recurrence after adjuvant chemotherapy and the association with survival ...
Robert P. Jones, E. Psarelli, R. Jackson, P. Ghaneh, C. Halloran, D. Palmer, F. Campbell, J. Valle, O. Faluyi, D. O’reilly, D. Cunningham, J. Wadsley, S. Darby, T. Meyer, R. Gillmore, A. Anthoney, P. Lind, B. Glimelius, S. Falk, J. Izbicki, G. Middleton, S. Cummins, P. Ross, H. Wasan, A. Mcdonald, T. Crosby, Yu Ting, K. Patel, David Sherriff, R. Soomal, D. Borg, S. Sothi, P. Hammel, M. Lerch, J. Mayerle, C. Tjaden, O. Strobel, T. Hackert, M. Büchler, J. Neoptolemos   +39 more
semanticscholar   +1 more source

Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma

Thoracic Cancer, 2023
Background The role of adjuvant chemotherapy in esophageal squamous cell carcinoma (ESCC) remains controversial. This study aimed to evaluate the impact of adjuvant chemotherapy on survival in patients with positive nodes after surgery for ESCC.
Yeong Jeong Jeon, Jong Ho Cho, Yong Soo Choi, Young Mog Shim, Jong‐Mu Sun, Hong Kwan Kim   +5 more
doaj   +1 more source

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.

New England Journal of Medicine, 2019
BACKGROUND Stage III or IVA endometrial cancer carries a significant risk of systemic and locoregional recurrence. METHODS In this randomized phase 3 trial, we tested whether 6 months of platinum-based chemotherapy plus radiation therapy ...
D. Matei, V. Filiaci, M. Randall, D. Mutch, M. Steinhoff, P. DiSilvestro, K. Moxley, Y. M. Kim, M. Powell, D. O’Malley, N. Spirtos, W. Small, K. Tewari, W. E. Richards, J. Nakayama, U. Matulonis, Helen Q. Huang, D. Miller   +17 more
semanticscholar   +1 more source

Adjuvant chemotherapy: an autoethnography [PDF]

Subjectivity, 2017
Adjuvant chemotherapy is given after surgery for early stage cancer. It aims to cure. Though potentially toxic, it has dramatically improved survival for some cancers. This paper offers an autoethnographic exploration of three kinds of strangeness that I encountered during a 12-week course of adjuvant chemotherapy for early breast cancer: the material ...
openaire   +2 more sources

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.

Journal of Clinical Oncology, 2018
Purpose The contribution of adjuvant chemotherapy after chemoradiation therapy (CRT) in nasopharyngeal cancer (NPC) remains controversial. Plasma Epstein-Barr virus (EBV) DNA is a potential biomarker of subclinical residual disease in NPC.
A. Chan, E. Hui, R. Ngan, S. Tung, A. Cheng, W. Ng, V. Lee, B. Ma, Hoi-Ching Cheng, F. Wong, H. Loong, M. Tong, D. Poon, A. Ahuja, A. King, Ki Wang, F. Mo, B. Zee, K. C. Chan, Y. Lo   +19 more
semanticscholar   +1 more source

The practical roadmap for peri-cystectomy approaches in muscle-invasive bladder cancer

Frontiers in Oncology
The management of muscle-invasive bladder cancer (MIBC) remains a challenging topic since it is witnessing rapidly evolving changes and new drug approvals. In fact, more effective approaches are now available to improve the outcomes of patients with MIBC
Joseph Kattan, Clarisse Kattan, Fouad Aoun, Elie Nemr   +3 more
doaj   +1 more source

Adjuvant Chemotherapy in Patients with Node-Negative Non-Small Cell Lung Cancer with Satellite Pulmonary Nodules in the Same Lobe

Journal of Chest Surgery, 2022
Background: According to the eighth TNM (tumor-node-metastasis) staging system, the presence of separate tumor nodules in the same lobe is designated as a T3 descriptor.
Jiyoun Park, Junghee Lee, Yeong Jeong Jeon, Sumin Shin, Jong Ho Cho, Hong-Kwan Kim, Yong Soo Choi, Jhingook Kim, Jae Ill Zo, Young Mog Shim   +9 more
doaj   +1 more source